NCCN Guidelines® Insights: Management of Immunotherapy-Related Toxicities, version 2.2024: Featured updates to the NCCN Guidelines Guidelines


Authors: Thompson, J. A.; Schneider, B. J.; Brahmer, J.; Zaid, M. A.; Achufusi, A.; Armand, P.; Berkenstock, M. K.; Bermas, B.; Braaten, T.; Budde, L. E.; Chokshi, S.; Crees, Z. D.; Davies, M.; Deng, C.; Gesthalter, Y.; Jain, M.; Jain, P.; Jallouk, A.; Kaffenberger, B. H.; Khalil, M.; Lechner, M. G.; Li, T.; Marr, A.; McGettigan, S.; McPherson, J.; Medina, T.; Mohindra, N. A.; Olszanski, A. J.; Oluwole, O.; Patel, S. P.; Prosek, J.; Reddy, S.; Reid, P.; Ryan, J.; Ryder, M.; Salman, H.; Santomasso, B.; Shofer, S.; Sosman, J. A.; Wang, Y.; Zaha, V. G.; Zucker, S.; Lyons, M.; Awotiwon, A.; Hang, L.
Title: NCCN Guidelines® Insights: Management of Immunotherapy-Related Toxicities, version 2.2024: Featured updates to the NCCN Guidelines
Abstract: The NCCN Guidelines for the Management of Immunotherapy-Related Toxicities are intended to provide oncology practitioners with guidance on how to manage the wide-ranging and potentially fatal toxicities that may occur with cancer immunotherapy. The guidelines address immune-related adverse events related to immune checkpoint inhibitors, CAR T-cell therapies, and lymphocyte engagers (which include T-cell-engaging bispecific antibodies). These NCCN Guidelines Insights highlight recent guideline updates pertaining to the management of emerging toxicities related to cancer immunotherapy.
Keywords: neoplasm; neoplasms; practice guideline; oncology; immunology; immunotherapy; diagnosis; medical oncology; disease management; drug therapy; adverse drug reaction; therapy; etiology; adverse event; procedures; immune checkpoint inhibitor; humans; human; drug-related side effects and adverse reactions; immune checkpoint inhibitors
Journal Title: Journal of the National Comprehensive Cancer Network
Volume: 22
Issue: 9
ISSN: 1540-1405
Publisher: Harborside Press  
Date Published: 2024-11-01
Start Page: 582
End Page: 592
Language: English
DOI: 10.6004/jnccn.2024.0057
PUBMED: 39536465
PROVIDER: scopus
DOI/URL:
Notes: Article -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors